GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Hercules Capital Inc (NYSE:HTGC) » Definitions » Valuation Rank

Hercules Capital (Hercules Capital) Valuation Rank


View and export this data going back to 2005. Start your Free Trial

What is Hercules Capital Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Hercules Capital Valuation Rank Related Terms

Thank you for viewing the detailed overview of Hercules Capital's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Hercules Capital (Hercules Capital) Business Description

Traded in Other Exchanges
Address
400 Hamilton Avenue, Suite 310, Palo Alto, CA, USA, 94301
Hercules Capital Inc is a specialty finance company engaged in providing senior secured loans to high-growth, venture capital-backed companies in a variety of technology, life sciences, and sustainable and renewable technology industries. It invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.
Executives
Nikos Theodosopoulos director C/O ARISTA NETWORKS, INC., 5453 GREAT AMERICA PARKWAY, SANTA CLARA CA 95054
Christian Follmann officer: Chief Operating Officer C/O HERCULES CAPITAL, INC., 400 HAMILTON AVENUE, SUITE 310, PALO ALTO CA 94301
Gayle A Crowell director
Wade Loo director C/O HERCULES CAPITAL, INC., 400 HAMILTON AVENUE, SUITE 310, PALO ALTO CA 94301
Scott Bluestein officer: Chief Investment Officer 303 COLUMBUS AVENUE, APT 506, BOSTON MA 02116
Deanne Aguirre director C/O HERCULES CAPITAL, INC., 400 HAMILTON AVENUE, SUITE 310, PALO ALTO CA 94301
Thomas J Fallon director C/O INFINERA CORPORATION, 140 CASPIAN COURT, SUNNYVALE CA 94089
Kiersten Zaza Botelho officer: General Counsel & CCO C/O HERCULES CAPITAL, INC., 400 HAMILTON AVENUE, SUITE 310, PALO ALTO CA 94301
Paramjeet K Randhawa director C/O HERCULES CAPITAL, INC., 400 HAMILTON AVENUE, SUITE 310, PALO ALTO CA 94301
Carol L Foster director C/O HERCULES CAPITAL, INC., 400 HAMILTON AVENUE, SUITE 310, PALO ALTO CA 94301
Seth H Meyer officer: Chief Financial Officer C/O HERCULES CAPITAL, INC., 400 HAMILTON AVENUE, SUITE 310, PALO ALTO CA 94301
Jorge Titinger director 7005 SOUTHFRONT ROAD, LIVERMORE CA 94551
Doreen Woo Ho director C/O HERCULES CAPITAL, INC., 400 HAMILTON AVENUE, SUITE 310, PALO ALTO CA 94301
Waldt Gerard R Jr. officer: Interim Chief Accounting Off 400 HAMILTON AVENUE SUITE 310, PALO ALTO CA 94301
Bradford C. Koenig director C/O GSV CAPITAL CORP., 2925 WOODSIDE ROAD, WOODSIDE CA 94062